158 related articles for article (PubMed ID: 8645724)
21. Activation of rat liver cytosolic 3-hydroxy-3-methylglutaryl coenzyme A reductase kinase by adenosine 5'-monophosphate.
Ferrer A; Caelles C; Massot N; Hegardt FG
Biochem Biophys Res Commun; 1985 Oct; 132(2):497-504. PubMed ID: 4062938
[TBL] [Abstract][Full Text] [Related]
22. Kinase-independent transcriptional co-activation of peroxisome proliferator-activated receptor alpha by AMP-activated protein kinase.
Bronner M; Hertz R; Bar-Tana J
Biochem J; 2004 Dec; 384(Pt 2):295-305. PubMed ID: 15312046
[TBL] [Abstract][Full Text] [Related]
23. Contraction-induced fatty acid translocase/CD36 translocation in rat cardiac myocytes is mediated through AMP-activated protein kinase signaling.
Luiken JJ; Coort SL; Willems J; Coumans WA; Bonen A; van der Vusse GJ; Glatz JF
Diabetes; 2003 Jul; 52(7):1627-34. PubMed ID: 12829625
[TBL] [Abstract][Full Text] [Related]
24. Dual mechanisms regulating AMPK kinase action in the ischemic heart.
Baron SJ; Li J; Russell RR; Neumann D; Miller EJ; Tuerk R; Wallimann T; Hurley RL; Witters LA; Young LH
Circ Res; 2005 Feb; 96(3):337-45. PubMed ID: 15653571
[TBL] [Abstract][Full Text] [Related]
25. Purification and characterization of the AMP-activated protein kinase. Copurification of acetyl-CoA carboxylase kinase and 3-hydroxy-3-methylglutaryl-CoA reductase kinase activities.
Carling D; Clarke PR; Zammit VA; Hardie DG
Eur J Biochem; 1989 Dec; 186(1-2):129-36. PubMed ID: 2598924
[TBL] [Abstract][Full Text] [Related]
26. Stimulation of hepatocytic AMP-activated protein kinase by okadaic acid and other autophagy-suppressive toxins.
Samari HR; Møller MT; Holden L; Asmyhr T; Seglen PO
Biochem J; 2005 Mar; 386(Pt 2):237-44. PubMed ID: 15461583
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of glycolysis by 5-amino-4-imidazolecarboxamide riboside in isolated rat hepatocytes.
Vincent MF; Bontemps F; Van den Berghe G
Biochem J; 1992 Jan; 281 ( Pt 1)(Pt 1):267-72. PubMed ID: 1531010
[TBL] [Abstract][Full Text] [Related]
28. Affinity labeling of the catalytic and AMP allosteric sites of 3-hydroxy-3-methylglutaryl-coenzyme A reductase kinase by 5'-p-fluorosulfonylbenzoyladenosine.
Ferrer A; Caelles C; Massot N; Hegardt FG
J Biol Chem; 1987 Oct; 262(28):13507-12. PubMed ID: 3654627
[TBL] [Abstract][Full Text] [Related]
29. Stimulation of AMP-activated protein kinase (AMPK) is associated with enhancement of Glut1-mediated glucose transport.
Abbud W; Habinowski S; Zhang JZ; Kendrew J; Elkairi FS; Kemp BE; Witters LA; Ismail-Beigi F
Arch Biochem Biophys; 2000 Aug; 380(2):347-52. PubMed ID: 10933890
[TBL] [Abstract][Full Text] [Related]
30. Cell-type specificity of inhibition of glycolysis by 5-amino-4-imidazolecarboxamide riboside. Lack of effect in rabbit cardiomyocytes and human erythrocytes, and inhibition in FTO-2B rat hepatoma cells.
Javaux F; Vincent MF; Wagner DR; van den Berghe G
Biochem J; 1995 Feb; 305 ( Pt 3)(Pt 3):913-9. PubMed ID: 7848293
[TBL] [Abstract][Full Text] [Related]
31. AMP-activated protein kinase phosphorylates transcription factors of the CREB family.
Thomson DM; Herway ST; Fillmore N; Kim H; Brown JD; Barrow JR; Winder WW
J Appl Physiol (1985); 2008 Feb; 104(2):429-38. PubMed ID: 18063805
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of insulin-stimulated glycogen synthesis by 5-aminoimidasole-4-carboxamide-1-beta-d-ribofuranoside-induced adenosine 5'-monophosphate-activated protein kinase activation: interactions with Akt, glycogen synthase kinase 3-3alpha/beta, and glycogen synthase in isolated rat soleus muscle.
Fediuc S; Gaidhu MP; Ceddia RB
Endocrinology; 2006 Nov; 147(11):5170-7. PubMed ID: 16873531
[TBL] [Abstract][Full Text] [Related]
33. Allosteric activation of rat liver microsomal [hydroxymethylglutaryl-CoA reductase (NADPH)]kinase by nucleoside phosphates.
Ferrer A; Caelles C; Massot N; Hegardt FG
Biol Chem Hoppe Seyler; 1987 Mar; 368(3):249-57. PubMed ID: 3689494
[TBL] [Abstract][Full Text] [Related]
34. Influence of malonyl-CoA and palmitate concentration on rate of palmitate oxidation in rat muscle.
Merrill GF; Kurth EJ; Rasmussen BB; Winder WW
J Appl Physiol (1985); 1998 Nov; 85(5):1909-14. PubMed ID: 9804598
[TBL] [Abstract][Full Text] [Related]
35. Insulin stimulation of glucose uptake fails to decrease palmitate oxidation in muscle if AMPK is activated.
Winder WW; Holmes BF
J Appl Physiol (1985); 2000 Dec; 89(6):2430-7. PubMed ID: 11090599
[TBL] [Abstract][Full Text] [Related]
36. Reaction of 5'-p-fluorosulfonylbenzoyladenosine with the catalytic and AMP allosteric sites of microsomal HMG-CoA reductase kinase.
Ferrer A; Caelles C; Hegardt FG
Biochem Biophys Res Commun; 1987 Nov; 148(3):1009-16. PubMed ID: 3689380
[TBL] [Abstract][Full Text] [Related]
37. Regulation of fatty acid oxidation and glucose metabolism in rat soleus muscle: effects of AICAR.
Kaushik VK; Young ME; Dean DJ; Kurowski TG; Saha AK; Ruderman NB
Am J Physiol Endocrinol Metab; 2001 Aug; 281(2):E335-40. PubMed ID: 11440910
[TBL] [Abstract][Full Text] [Related]
38. Glycogen-dependent effects of 5-aminoimidazole-4-carboxamide (AICA)-riboside on AMP-activated protein kinase and glycogen synthase activities in rat skeletal muscle.
Wojtaszewski JF; Jørgensen SB; Hellsten Y; Hardie DG; Richter EA
Diabetes; 2002 Feb; 51(2):284-92. PubMed ID: 11812734
[TBL] [Abstract][Full Text] [Related]
39. 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) inhibits insulin-stimulated glucose transport in 3T3-L1 adipocytes.
Salt IP; Connell JM; Gould GW
Diabetes; 2000 Oct; 49(10):1649-56. PubMed ID: 11016448
[TBL] [Abstract][Full Text] [Related]
40. Impact of in vivo fatty acid oxidation blockade on glucose turnover and muscle glucose metabolism during low-dose AICAR infusion.
Christopher M; Rantzau C; Chen ZP; Snow R; Kemp B; Alford FP
Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E1131-40. PubMed ID: 16772328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
